Objective: To develop and validate new Juvenile Arthritis Disease Activity Score 10 (JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive disease (ID), minimal disease activity (MiDA), moderate disease activity (MoDA), and high disease activity (HDA) in children with oligoarthritis and with rheumatoid...
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2020 (v1)Publication
In the first version of the paper, two of the three subheadings in Table 2 were spelt incorrectly. Takayasu Arthritis has vbeen changed to Takayasu arteritis. This error only appeared in two subheadings. The stated recommendations and main article text have not been affected or changed. The Publisher and authors apologise for this error.
Uploaded on: April 14, 2023 -
2017 (v1)Publication
Background In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases. Juvenile dermatomyositis ( JDM) is a rare disease within the group of paediatric...
Uploaded on: April 14, 2023 -
2010 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Background: To our knowledge, the characteristics and burden of childhood arthritis have never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study, the prevalence of disease categories, treatment methods, and disease status in patients from across different geographical areas and from countries with diverse...
Uploaded on: March 27, 2023